Side effects are rare and typically limited to mild injection-site tenderness
Key Benefits of BPC 157 Injections Injectable delivery bypasses digestion and may allow for greater systemic exposure compared to oral forms
Okay, let me just disclaimer, this plan doesn't work for average people, doesn't work for me
The challenge is not whether GHK-Cu has biological activity (that is well-established) but whether that activity can be delivered to tissues at concentrations and durations sufficient to produce clinical effects beyond the skin surface
PMID: 41209547 References are provided for research reference only
FDA has underlined the adverse effects of DPP-IV inhibitor drugs such as Januvia, Janumet, Janumet XR, Onglyza, Kombiglyze XR, Tradjenta, Glyxambi, Jentadueto, Nesina, Kazano, and Oseni with active compounds sitagliptin, sitagliptin and metformin, sitagliptin and metformin extended release, saxagliptin, saxagliptin and metformin extended release, linagliptin, linagliptin and empagliflozin, linagliptin and metformin, alogliptin, alogliptin and metformin andalogliptin, and pioglitazone, respectively (60)